Dangerous Prescription Drugs News

The Journal of the American Medical Association

Study Group Demands JAMA Retract Low-T Study

An ad hoc group of medical professionals is demanding the Journal of the American Medical Association (JAMA) retract an influential study that connects testosterone therapy and cardiovascular problems and investigate a possible ethical breach by the publication’s editorial board. The Androgen Study Group said JAMA violated ethical standards, created baseless concerns and “birthed a new […]

Aug 14, 2014 Read More...

Testosterone Therapy Drugs and Supplements

Testosterone Drugs Not Effective in Men with Type 2 Diabetes

Testosterone therapy did not help aging, obese men who have Type 2 diabetes and reduced testosterone levels with sexual symptoms and general health, a new study shows. Berlin-based Bayer Pharma AG who makes the testosterone drug Nebido funded the study published in The Journal of Clinical Endocrinology & Metabolism. Researchers found it is unlikely that […]

Jul 28, 2014 Read More...

Testosterone Products and Supplements

New Study Favors Testosterone Therapy, Fails to Look at Low T Products

A recently released study shows that the injectable form of low testosterone drugs do not increase the risk of a heart attack in older men. The study is being touted by companies that make so-called “Low-T” products, but it failed to address the more popular forms of this drug – like gels and pills – […]

Jul 9, 2014 Read More...

man working in lab with test tubes

New Studies Shed Light on Testosterone Therapy

Exercise, obesity and infertility are the major topics in the latest news on testosterone replacement therapy (TRT). Studies presented at the recent American Urological Association (AUA) meeting show that exercise improves the effect of testosterone therapy, while obesity reduces the success rate. One of the three studies on obesity showed that it actually could be […]

Jun 11, 2014 Read More...

Clarus Therapeutics Logo

Clarus Therapeutics Plans IPO, Oral Testosterone Drug

Amid the ongoing controversy over the safety of testosterone therapy, the maker of a new medication for low testosterone (Low T) plans an $86.2 million initial public offering (IPO) later this year. Clarus Therapeutics hopes to have its oral testosterone drug, Rextoro, to the Food and Drug Administration (FDA) for review by November. This marks […]

Jun 2, 2014 Read More...

men and women and hormone replacement

Men and Women Face Risks from Hormone Replacement Therapy

In 1966, Dr. Robert A. Wilson, a gynecologist, decided menopause was no longer a normal stage of life. “No woman can be sure of escaping the horror of this living decay,” he wrote in the popular book “Feminine Forever.” “There is no need for either valor or pretense. The need is for hormones.” Decades later, […]

May 15, 2014 Read More...

Loading